Article

Scleral incision system approved in Europe

Dallas-Refocus Group Inc. has received approval to market its PresVIEW scleral incision system in the European Union.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
Avoiding disasters and oculofacial surgery
August 31st 2025

Avoiding disasters and oculofacial surgery

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 31st 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Surgical innovation in dry eye disease: Salivary gland transplant
August 31st 2025

Surgical innovation in dry eye disease: Salivary gland transplant

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 31st 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections
August 31st 2025

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections

ASRS 2025: Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin
August 31st 2025

ASRS 2025: Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin

© 2025 MJH Life Sciences

All rights reserved.